Skip to main content
Log in

Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival

  • Original Article
  • Artificial Heart (Clinical)
  • Published:
Journal of Artificial Organs Aims and scope Submit manuscript

Abstract

Post-cardiotomy cardiogenic shock (PCCS) results in substantial morbidity and mortality, whereas refractory cases require mechanical circulatory support. The aim of this study was to evaluate factors influencing survival during short-term ventricular assist support in PCCS. In total, 154 CentriMag® (Thoratec; CA, USA) devices were implanted for cardiogenic shock between 2004 and 2011 out of which 31 were for PCCS. A retrospective review was performed in 31 PCCS patients who required the CentriMag short-term VAD as a bridge to decision. Survivors and non-survivors were compared with respect to pre- and intra-operative characteristics as well as duration of short-term VAD support. Mean duration of support was 11.7 ± 15.4 days (range 1–65 days). Seventeen (54.83 %) patients died on support, 14 (45.16 %) were weaned off or upgraded to long-term device, while 11 (35.5 %) were discharged home. The overall survival to myocardial recovery and device explantation, or upgrade to a long-term VAD, was 41.9 % (n = 13) at the study cutoff. EuroSCORE II was significantly higher in non-survivors as compared to survivors (p = 0.047). The duration of short-term VAD support was significantly longer in survivors (p < 0.001). The CentriMag is a versatile, safe and effective short-term circulatory support for patients with PCCS as a bridge to decision which enables longer support and better recovery of both heart and end-organ function and thus may improve the survival of PCCS patients. Lower EuroSCORE may be essential for myocardial recovery in PCCS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, et al. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002;106:203–6.

    Article  Google Scholar 

  2. Torchiana DF, Hirsch G, Buckley MJ, Hahn C, Allyn JW, Akins CW, et al. Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg. 1997;113:758–64.

    Article  CAS  PubMed  Google Scholar 

  3. Baskett RJF, Ghali WA, Maitland A, Hirsh GM. The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg. 2002;74:1276–87.

    Article  PubMed  Google Scholar 

  4. Arafa OE, Pedersen TH, Svennevig JL, Fosse E, Geiran OR. Intraaortic balloon pump in open heart operations: 10-year follow-up with risk analysis. Ann Thorac Surg. 1998;65:741–7.

    Article  CAS  PubMed  Google Scholar 

  5. Nasir A, Bonde P, Graham AN. Ventricular assist device therapy in post-cardiotomy cardiogenic shock: historical outcomes and current trends. Interact CardioVasc Thorac Surg. 2012;14:585–7.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Hernandez AF, Grab JD, Gammie JS, O’Brien SM, Hammill BG, Rogers JG, et al. A decade of short-term outcomes in post cardiac surgery ventricular assist device implantation: data from the Society of Thoracic Surgeons’ National Cardiac Database. Circulation. 2007;116:606–12.

    Article  PubMed  Google Scholar 

  7. Pae WE Jr, Miller CA, Matthews Y, Pierce WS. Ventricular assist devices for postcardiotomy cardiogenic shock: a combined registry experience. J Thorac Cardiovasc Surg. 1992;104:541–52.

    PubMed  Google Scholar 

  8. Jurmann MJ, Siniawski H, Erb M, Drews T, Hetzer R. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure. Ann Thorac Surg. 2004;77:1642–7.

    Article  PubMed  Google Scholar 

  9. Noon GP, Lafuente JA, Irwin S. Acute and temporary ventricular support with BioMedicus centrifugal pump. Ann Thorac Surg. 1999;68:650–4.

    Article  CAS  PubMed  Google Scholar 

  10. Parascandola SA, Pae WE Jr, Davis PK, Miller CA, Pierce WS, Waldhausen JA. Determinants of survival in patients with ventricular assist devices. ASAIO Trans. 1988;34:222–8.

    CAS  PubMed  Google Scholar 

  11. Samuels LE, Kaufman MS, Thomas MP, Holmes EC, Brockman SK, Wechsler AS. Pharmacological criteria for ventricular assist device insertion following postcardiotomy shock. J Card Surg. 1999;14:288–93.

    Article  CAS  PubMed  Google Scholar 

  12. Nashef SA, Roques F, Michel P, Gauducheau E, Lemeshow S, Salamon R. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.

    Article  CAS  PubMed  Google Scholar 

  13. Michalopoulos A, Tzelepis G, Dafni U, Geroulanos S. Determinants of hospital mortality after coronary artery bypass grafting. Chest. 1999;115:1598–603.

    Article  CAS  PubMed  Google Scholar 

  14. Klotz S, Vahlhaus C, Riehl C, Reitz C, Sindermann JR, Scheld HH. Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters. J Heart Lung Transplant. 2010;29:45–52.

    Article  PubMed  Google Scholar 

  15. Lund LH, Matthews J, Aaronson K. Patient selection for left ventricular assist devices. Eur J Heart Fail. 2010;12:434–43.

    Article  PubMed  Google Scholar 

  16. Kitamura M, Aomi S, Hachida M, Nishida H, Endo M, Koyanagi H. Determinants of clinical results of mechanical circulatory support for ventricular failure after cardiotomy. ASAIO. 1996;42:729–32.

    Article  Google Scholar 

  17. John R, Liao K, Lietz K, Kamdar F, Colvin-Adams M, Boyle A, et al. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure. J Thorac Cardiovasc Surg. 2007;134:351–8.

    Article  PubMed  Google Scholar 

  18. John R, Long JW, Massey HT, Griffith BP, Sun BC, Tector AJ, et al. Outcomes of a multicenter trial of the Levitronix CentriMag ventricular assist system for short-term circulatory support. J Thorac Cardiovasc Surg. 2011;141:932–9.

    Article  PubMed  Google Scholar 

  19. Mohite PN, Zych B, Popov AF, Sabashnikov A, Sáez DG, Patil NP, et al. CentriMag short-term ventricular assist as a bridge to solution in patients with advanced heart failure: use beyond 30 days. Eur J Cardiothorac Surg. 2013;44:e310–5.

    Article  PubMed  Google Scholar 

  20. DeRobertis F, Birks EJ, Rogers P, et al. Clinical performance with the Levitronix CentriMag short-term ventricular assist device. J Heart Lung Transplant. 2006;25:181–6.

    Article  CAS  Google Scholar 

  21. Thoratec® CentriMag® Blood Pump, official web page of the Thoratec Corporation, http://www.thoratec.com/medical-professionals/vad-product-information/thoratec-centrimag.aspx Accessed 29 Dec 2013.

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Anton Sabashnikov.

Additional information

Prashant N. Mohite and Anton Sabashnikov have contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohite, P.N., Sabashnikov, A., Patil, N.P. et al. Short-term ventricular assist device in post-cardiotomy cardiogenic shock: factors influencing survival. J Artif Organs 17, 228–235 (2014). https://doi.org/10.1007/s10047-014-0773-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10047-014-0773-1

Keywords

Navigation